Summary & Overview
CPT 96409: Intravenous Push Chemotherapy, Single or Initial Drug
CPT code 96409 denotes administration of a chemotherapy agent by intravenous push for a single or initial drug. Nationally relevant for oncology practices and hospital outpatient infusion centers, this code identifies a specific, brief administration technique distinct from infusion or infusion pump services. Clear coding of 96409 affects billing accuracy, aggregation of chemotherapy utilization, and claims adjudication across public and commercial payers.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, comparative payer coverage context, common billing modifiers and coding considerations, and where 96409 fits within chemotherapy service lines. The publication summarizes billing benchmarks, documentation expectations tied to single or initial drug IV push administrations, and policy or reimbursement updates that commonly affect how payers process this service type.
This material is intended for coding professionals, revenue cycle managers, and clinical billing staff seeking a national-level reference on applying CPT code 96409 for IV push chemotherapy administrations. Data not available in the input will be explicitly noted in relevant sections.
Billing Code Overview
CPT code 96409 describes the administration of a chemotherapy drug by intravenous push. This code is used when a provider administers a single or initial chemotherapeutic agent using an IV push technique.
-
Service type: Chemotherapy administration (intravenous push), single or initial drug
-
Typical site of service: Outpatient infusion clinic or hospital outpatient department where IV push chemotherapy is provided
Clinical & Coding Specifications
Clinical Context
A 62-year-old female with metastatic breast cancer presents to the infusion clinic for administration of a single-agent chemotherapy dose. The oncology advanced practice provider reviews vital signs and labs, confirms chemotherapy orders, verifies informed consent, and performs line access assessment. The provider administers the chemotherapy drug via an intravenous push (bolus) through a peripheral IV or implanted port, observes the patient for immediate adverse reactions for the required monitoring period, documents drug name, dose, route, site, lot number, and start/stop times, and communicates aftercare instructions. Typical workflow includes order verification by pharmacy, bedside medication preparation, clinician verification of patient identity and pre-medications, IV push administration using aseptic technique, post‑administration observation, and documentation in the medical record. Typical sites of service are hospital outpatient infusion centers, physician offices, ambulatory infusion suites, and oncology clinics.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is provided on the same day as 96409 and is documented separately. |